JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Okta Announces Pricing of Initial Public Offering
-
JMP Securities Reiterates Market Outperform and $65 PT on Tableau Software (DATA) Following Subscription Pricing Announcement
-
Houlihan Lokey (HLI) PT Raised to $36 at JMP Securities
-
JMP Securities Upgrades NetApp (NTAP) to Market Perform
-
BioLineRx Closes $28.75 Million Underwritten Public Offering of its American Depositary Shares
-
Acuity Brands (AYI) PT Lowered to $155 at JMP Securities
-
JMP Securities Starts iStar Financial (STAR) at Market Perform
-
SteadyMed (STDY) PT Raised to $17 at JMP Securities Amid Patent Win RemoSynch Delay
-
JMP Securities Reiterates Market Outperform Rating and $32 PT on MINDBODY (MB); 'Investors Worried About Competition Can Relax'
-
Novocure (NVCR): Positive PANOVA and INNOVATE Trials - JMP
-
Cloverpop Honored as "Hot 100" Company by JMP Securities
-
First Cash Financial Services (FCFS): Raising PT - JMP
-
Egalet to Participate in Spring Investor Conferences
-
JMP Securities Upgrades Forward Pharma (FWP) to Market Perform
-
JMP Securities Upgrades Meritage Homes (MTH) to Market Outperform
-
Carvana Files Registration Statement for Proposed Initial Public Offering
-
Don't Be Surprised if Boston Scientific (BSX) Buys Neovasc (NVCN)- JMP
-
BioLineRx (BLRX) Prices 29.4M Offering at $0.85/ADS
-
BioLineRx Prices $25 Million Underwritten Public Offering
-
JMP Securities Starts Colony NorthStar (CLNS) at Market Perform
-
BioLineRx (BLRX) to Offer ADSs
-
BioLineRx Announces Underwritten Public Offering of its American Depositary Shares
-
Corbus Pharmaceuticals (CRBP) PT Raised to $27 at JMP Securities
-
JMP Securities Downgrades Five Oaks Investment (OAKS) to Market Perform
-
Amazon Connect Not Seen as a Threat to Twilio (TWLO) - JMP
-
Cloudian Named by JMP Securities in 'Super 60' Hot Companies List
-
JMP Securities Reiterates Market Outperform on Aerie Pharma (AERI)
-
JMP Reiterates Market Outperform Rating and $45 PT on AnaptysBio (ANAB); Dupixent Approval Positive for ANB020
-
JMP Securities Reinstates Innocoll (INNL) at Market Outperform
-
Calithera Biosciences (CALA) PT Raised to $17 at JMP Securities Following Recent Developments with CB-839 & CB-1158
-
Vertex (VRTX) PT Raised to $121 at JMP Securities; Securing Triple Could But Company 'In Play'
-
DepoMed Inc (DEPO) PT Lowered to $16 at JMP Securities, Lowers FY 2017/2018 EP Estimate
-
Big Switch Networks Named to JMP Securities' Super 60 List
-
JMP Securities Reiterates Market Outperform Rating and $12 PT on Calithera Biosciences (CALA) Following Achievement of PK & PD Goals in Ph1 Trial of CB-1158
-
Calithera Biosciences, Inc. Announces Closing of Public Offering and Exercise in Full of Option to Purchase Additional Shares
-
Snap (SNAP) Quiet Period Ends, Recap Of Ratings And PTs From Sell-Side
-
JMP Securities Starts Snap Inc (SNAP) at Market Outperform, "One Of The Most Innovative Companies"
-
JMP Securities Downgrades KB Home (KBH) to Market Perform Citing Valuation
-
Alteryx (AYX) IPO Opens Up 23%
-
Cherry Hill Mortgage Investment (CHMI) Prices 4.5M Share Secondary at $16.50
-
Alteryx Announces Pricing of Initial Public Offering
-
Cherry Hill Mortgage Investment Corporation Announces Pricing of Public Offering of Common Stock
-
Digital Guardian Named to JMP Securities Super 60 List of the Hottest Privately Held Companies
-
Intercept Pharmaceuticals (ICPT): Phase 2 Data Anticipated Mid-Year - JMP
-
Cherry Hill Mortgage Investment (CHMI) to Offer 4.5M in Common Stock
-
Cherry Hill Mortgage Investment Corporation Announces Public Offering of Common Stock
-
Cybereason Announces 300 Percent Revenue Growth in 2016
-
Blueprint Medicines (BPMC): Raising PT on Phase I Dosing - JMP
-
JMP Securities Remains Bullish on Adobe Systems (ADBE) Following Summit
-
Calithera Biosciences (CALA) Prices 6.83M Common Stock Offering at $10.25/Share

